Cargando…

Barriers and facilitators experienced in collaborative prospective research in orthopaedic oncology: A qualitative study

OBJECTIVES: As tumours of bone and soft tissue are rare, multicentre prospective collaboration is essential for meaningful research and evidence-based advances in patient care. The aim of this study was to identify barriers and facilitators encountered in large-scale collaborative research by orthop...

Descripción completa

Detalles Bibliográficos
Autores principales: Rendon, J. S., Swinton, M., Bernthal, N., Boffano, M., Damron, T., Evaniew, N., Ferguson, P., Galli Serra, M., Hettwer, W., McKay, P., Miller, B., Nystrom, L., Parizzia, W., Schneider, P., Spiguel, A., Vélez, R., Weiss, K., Zumárraga, J. P., Ghert, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457637/
https://www.ncbi.nlm.nih.gov/pubmed/28515060
http://dx.doi.org/10.1302/2046-3758.65.BJR-2016-0192.R1
_version_ 1783241584713662464
author Rendon, J. S.
Swinton, M.
Bernthal, N.
Boffano, M.
Damron, T.
Evaniew, N.
Ferguson, P.
Galli Serra, M.
Hettwer, W.
McKay, P.
Miller, B.
Nystrom, L.
Parizzia, W.
Schneider, P.
Spiguel, A.
Vélez, R.
Weiss, K.
Zumárraga, J. P.
Ghert, M.
author_facet Rendon, J. S.
Swinton, M.
Bernthal, N.
Boffano, M.
Damron, T.
Evaniew, N.
Ferguson, P.
Galli Serra, M.
Hettwer, W.
McKay, P.
Miller, B.
Nystrom, L.
Parizzia, W.
Schneider, P.
Spiguel, A.
Vélez, R.
Weiss, K.
Zumárraga, J. P.
Ghert, M.
author_sort Rendon, J. S.
collection PubMed
description OBJECTIVES: As tumours of bone and soft tissue are rare, multicentre prospective collaboration is essential for meaningful research and evidence-based advances in patient care. The aim of this study was to identify barriers and facilitators encountered in large-scale collaborative research by orthopaedic oncological surgeons involved or interested in prospective multicentre collaboration. METHODS: All surgeons who were involved, or had expressed an interest, in the ongoing Prophylactic Antibiotic Regimens in Tumour Surgery (PARITY) trial were invited to participate in a focus group to discuss their experiences with collaborative research in this area. The discussion was digitally recorded, transcribed and anonymised. The transcript was analysed qualitatively, using an analytic approach which aims to organise the data in the language of the participants with little theoretical interpretation. RESULTS: The 13 surgeons who participated in the discussion represented orthopaedic oncology practices from seven countries (Argentina, Brazil, Italy, Spain, Denmark, United States and Canada). Four categories and associated themes emerged from the discussion: the need for collaboration in the field of orthopaedic oncology due to the rarity of the tumours and the need for high level evidence to guide treatment; motivational factors for participating in collaborative research including establishing proof of principle, learning opportunity, answering a relevant research question and being part of a collaborative research community; barriers to participation including funding, personal barriers, institutional barriers, trial barriers, and administrative barriers and facilitators for participation including institutional facilitators, leadership, authorship, trial set-up, and the support of centralised study coordination. CONCLUSIONS: Orthopaedic surgeons involved in an ongoing international randomised controlled trial (RCT) were motivated by many factors to participate. There were a number of barriers to and facilitators for their participation. There was a collective sense of fatigue experienced in overcoming these barriers, which was mirrored by a strong collective sense of the importance of, and need for, collaborative research in this field. The experiences were described as essential educational first steps to advance collaborative studies in this area. Knowledge gained from this study will inform the development of future large-scale collaborative research projects in orthopaedic oncology. Cite this article: J. S. Rendon, M. Swinton, N. Bernthal, M. Boffano, T. Damron, N. Evaniew, P. Ferguson, M. Galli Serra, W. Hettwer, P. McKay, B. Miller, L. Nystrom, W. Parizzia, P. Schneider, A. Spiguel, R. Vélez, K. Weiss, J. P. Zumárraga, M. Ghert. Barriers and facilitators experienced in collaborative prospective research in orthopaedic oncology: A qualitative study. Bone Joint Res 2017;6:–314. DOI: 10.1302/2046-3758.65.BJR-2016-0192.R1.
format Online
Article
Text
id pubmed-5457637
institution National Center for Biotechnology Information
language English
publishDate 2017
record_format MEDLINE/PubMed
spelling pubmed-54576372017-06-09 Barriers and facilitators experienced in collaborative prospective research in orthopaedic oncology: A qualitative study Rendon, J. S. Swinton, M. Bernthal, N. Boffano, M. Damron, T. Evaniew, N. Ferguson, P. Galli Serra, M. Hettwer, W. McKay, P. Miller, B. Nystrom, L. Parizzia, W. Schneider, P. Spiguel, A. Vélez, R. Weiss, K. Zumárraga, J. P. Ghert, M. Bone Joint Res Oncology OBJECTIVES: As tumours of bone and soft tissue are rare, multicentre prospective collaboration is essential for meaningful research and evidence-based advances in patient care. The aim of this study was to identify barriers and facilitators encountered in large-scale collaborative research by orthopaedic oncological surgeons involved or interested in prospective multicentre collaboration. METHODS: All surgeons who were involved, or had expressed an interest, in the ongoing Prophylactic Antibiotic Regimens in Tumour Surgery (PARITY) trial were invited to participate in a focus group to discuss their experiences with collaborative research in this area. The discussion was digitally recorded, transcribed and anonymised. The transcript was analysed qualitatively, using an analytic approach which aims to organise the data in the language of the participants with little theoretical interpretation. RESULTS: The 13 surgeons who participated in the discussion represented orthopaedic oncology practices from seven countries (Argentina, Brazil, Italy, Spain, Denmark, United States and Canada). Four categories and associated themes emerged from the discussion: the need for collaboration in the field of orthopaedic oncology due to the rarity of the tumours and the need for high level evidence to guide treatment; motivational factors for participating in collaborative research including establishing proof of principle, learning opportunity, answering a relevant research question and being part of a collaborative research community; barriers to participation including funding, personal barriers, institutional barriers, trial barriers, and administrative barriers and facilitators for participation including institutional facilitators, leadership, authorship, trial set-up, and the support of centralised study coordination. CONCLUSIONS: Orthopaedic surgeons involved in an ongoing international randomised controlled trial (RCT) were motivated by many factors to participate. There were a number of barriers to and facilitators for their participation. There was a collective sense of fatigue experienced in overcoming these barriers, which was mirrored by a strong collective sense of the importance of, and need for, collaborative research in this field. The experiences were described as essential educational first steps to advance collaborative studies in this area. Knowledge gained from this study will inform the development of future large-scale collaborative research projects in orthopaedic oncology. Cite this article: J. S. Rendon, M. Swinton, N. Bernthal, M. Boffano, T. Damron, N. Evaniew, P. Ferguson, M. Galli Serra, W. Hettwer, P. McKay, B. Miller, L. Nystrom, W. Parizzia, P. Schneider, A. Spiguel, R. Vélez, K. Weiss, J. P. Zumárraga, M. Ghert. Barriers and facilitators experienced in collaborative prospective research in orthopaedic oncology: A qualitative study. Bone Joint Res 2017;6:–314. DOI: 10.1302/2046-3758.65.BJR-2016-0192.R1. 2017-06-03 /pmc/articles/PMC5457637/ /pubmed/28515060 http://dx.doi.org/10.1302/2046-3758.65.BJR-2016-0192.R1 Text en © 2017 Ghert et al. This is an open-access article distributed under the terms of the Creative Commons Attributions licence (CC-BY-NC), which permits unrestricted use, distribution, and reproduction in any medium, but not for commercial gain, provided the original author and source are credited.
spellingShingle Oncology
Rendon, J. S.
Swinton, M.
Bernthal, N.
Boffano, M.
Damron, T.
Evaniew, N.
Ferguson, P.
Galli Serra, M.
Hettwer, W.
McKay, P.
Miller, B.
Nystrom, L.
Parizzia, W.
Schneider, P.
Spiguel, A.
Vélez, R.
Weiss, K.
Zumárraga, J. P.
Ghert, M.
Barriers and facilitators experienced in collaborative prospective research in orthopaedic oncology: A qualitative study
title Barriers and facilitators experienced in collaborative prospective research in orthopaedic oncology: A qualitative study
title_full Barriers and facilitators experienced in collaborative prospective research in orthopaedic oncology: A qualitative study
title_fullStr Barriers and facilitators experienced in collaborative prospective research in orthopaedic oncology: A qualitative study
title_full_unstemmed Barriers and facilitators experienced in collaborative prospective research in orthopaedic oncology: A qualitative study
title_short Barriers and facilitators experienced in collaborative prospective research in orthopaedic oncology: A qualitative study
title_sort barriers and facilitators experienced in collaborative prospective research in orthopaedic oncology: a qualitative study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457637/
https://www.ncbi.nlm.nih.gov/pubmed/28515060
http://dx.doi.org/10.1302/2046-3758.65.BJR-2016-0192.R1
work_keys_str_mv AT rendonjs barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT swintonm barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT bernthaln barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT boffanom barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT damront barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT evaniewn barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT fergusonp barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT galliserram barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT hettwerw barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT mckayp barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT millerb barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT nystroml barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT parizziaw barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT schneiderp barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT spiguela barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT velezr barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT weissk barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT zumarragajp barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy
AT ghertm barriersandfacilitatorsexperiencedincollaborativeprospectiveresearchinorthopaediconcologyaqualitativestudy